Syndromic Respiratory Testing: Evaluation of Biofire FilmArray Pneumonia Panel
Care Process & Redesign
Technology
Centre for Allied Health & Pharmacy Excellence
National Healthcare Group
31 December 2023
To evaluate BioFire® Pneumonia Panel for its effectiveness in identifying pathogens in respiratory infections. BioFire® Pneumonia Panel enhances diagnosis speed and pathogen detection accuracy for respiratory infections.
Year Submitted: 2023
Published Date: 31 December 2023
Tags: Technology, Care Process ＆ Redesign, Medtech, Productivity, Manhour Saving, Quality Improvement, Job Effectiveness
About this Content
Aims
To evaluate BioFire® Pneumonia Panel for its effectiveness in identifying pathogens in respiratory infections.
Background
Respiratory infections require timely diagnostics for better management.
Methods
Compared results from BioFire® multiplex PCR and traditional culture methods.
Results
BioFire® detected 77 pathogens vs. 24 by culture methods; 75% concordance with routine tests.
Conclusion
BioFire® Pneumonia Panel enhances diagnosis speed and pathogen detection accuracy for respiratory infections.
Lessons Learnt
Syndromic panels can improve speed, accuracy, and cost efficiency but require clinical validation.
Additional Information
CAPE 2023 Merit Award
Keywords
Syndromic Testing, BioFire, Respiratory
Innovators' Details
Innovators' Details
Healthcare Cluster(s) | National Healthcare Group |
Organization(s) Involved | Tan Tock Seng Hospital |
Platform(s) | Centre for Allied Health & Pharmacy Excellence |
Healthcare Professional Group(s) | Allied Health |
Applicable Specialty or Discipline | Medical ＆ Laboratory Technology, Pulmonology |
Project Lead(s) | Joshua Lee |
Project Member(s) | Nurasilah Ismail |
Connect with this contributor!
Joshua Lee - joshua_jt_lee@ttsh.com.sg